Provided by Tiger Fintech (Singapore) Pte. Ltd.

IHS Holding Ltd

6.03
+0.23003.97%
Post-market: 6.02-0.0100-0.17%16:05 EDT
Volume:1.10M
Turnover:6.52M
Market Cap:2.02B
PE:-44.15
High:6.04
Open:5.80
Low:5.80
Close:5.80
Loading ...

IHS Holding, HealthEquity And 3 Stocks To Watch Heading Into Tuesday

Benzinga
·
18 Mar

IHS Holding Ltd expected to post earnings of 4 cents a share - Earnings Preview

Reuters
·
14 Mar

Press Release: Plymouth Industrial REIT Appoints Robert O. Stephenson to Board of Directors

Dow Jones
·
14 Mar

IHS Holding Ltd expected to post earnings of 4 cents a share - Earnings Preview

Reuters
·
07 Mar

Press Release: IHS Towers' Fourth Quarter and Full Year 2024 Earnings Release and Conference Call

Dow Jones
·
06 Mar

Axsome Therapeutics Announces SYMBRAVO® (meloxicam and rizatriptan) Achieves Primary Endpoint in the EMERGE Phase 3 Trial in Migraine Patients Experiencing Inadequate Response to Oral CGRP Inhibitors

GlobeNewswire
·
24 Feb

RBC Capital Remains a Buy on IHS Holding (IHS)

TIPRANKS
·
14 Feb

IHS Holding Ltd : RBC Cuts Target Price to $4.25 From $7

THOMSON REUTERS
·
11 Feb

Barclays Sticks to Its Buy Rating for IHS Holding (IHS)

TIPRANKS
·
06 Feb

Analysts Expect IHS Holding Limited (NYSE:IHS) To Breakeven Soon

Simply Wall St.
·
05 Feb

Axsome Therapeutics Hosts SYMBRAVO® FDA Approval Virtual Investor Event with Expert Thought Leader

GlobeNewswire
·
31 Jan

Axsome Therapeutics Announces FDA Approval of SYMBRAVO® (meloxicam and rizatriptan) for the Acute Treatment of Migraine with or without Aura in Adults

GlobeNewswire
·
31 Jan

ONWARD Medical's ARC-EX System Now Available on US Veterans Affairs Online Procurement Platforms

GlobeNewswire
·
29 Jan

Investors Aren't Buying IHS Holding Limited's (NYSE:IHS) Revenues

Simply Wall St.
·
24 Jan

Nyse Order Imbalance 70187.0 Shares on Buy Side

THOMSON REUTERS
·
23 Jan

IHS Holding Limited (IHS) Stock: An Under $5 Gem with Biggest Upside Potential

Insider Monkey
·
21 Jan

Anterix (ATEX) Moves 11.4% Higher: Will This Strength Last?

Zacks
·
21 Jan